NCT00728338View on ClinicalTrials.gov

Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Hypertriglyceridemia
Interventions
DIETARY_SUPPLEMENT

Docosahexenoic acid (DHA)

The DHA group received 7.5 g/d DHA oil (DHA 3.0 g/d) which is produced in the microalga Crypthecodinium cohinii.

DIETARY_SUPPLEMENT

Olive oil

7.5 g olive oil/day

Trial Locations (1)

95616

Usda, Ars, Whnrc, Davis

All Listed Sponsors
collaborator

VA Northern California Health Care System

FED

collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

USDA, Western Human Nutrition Research Center

FED

NCT00728338 - Docosahexenoic Acid (DHA) Supplementation and Cardiovascular Disease in Men With High Triglycerides | Biotech Hunter | Biotech Hunter